InvestSMART

MMJ Group Holdings Limited (ASX: MMJ) - Announcements

Current share price for MMJ : $0.059 0.002 (3.51%)+

ASX company news and announcements for MMJ Group Holdings Limited (MMJ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MMJ Group Holdings Limited (MMJ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MMJ Group Holdings Limited (MMJ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MMJ Group Holdings Limited (MMJ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Half Year Accounts 25 Feb 2019 8:24AM $0.250 $0.059 fallen by 76.40%
- Results of Meeting 22 Feb 2019 3:53PM $0.250 $0.059 fallen by 76.40%
- Capital raising in 2019 an update 22 Feb 2019 9:48AM $0.255 $0.059 fallen by 76.86%
- Portfolio Update Fire and Flower 20 Feb 2019 10:34AM $0.255 $0.059 fallen by 76.86%
- Investment in Trichomia 14 Feb 2019 3:43PM $0.250 $0.059 fallen by 76.40%
- MediPharm Labs Signs $35 Million Private Label Cannabis Oil 13 Feb 2019 10:34AM $0.250 $0.059 fallen by 76.40%
- Net Tangible Asset Backing 12 Feb 2019 9:55AM $0.235 $0.059 fallen by 74.89%
- MediPharm Labs management team changes 8 Feb 2019 9:31AM $0.235 $0.059 fallen by 74.89%
- Fire & Flower TSX-V listing 8 Feb 2019 9:29AM $0.235 $0.059 fallen by 74.89%
- CEO resignation 4 Feb 2019 8:55AM $0.250 $0.059 fallen by 76.40%
- Harvest One launches Satipharm reformulated CBD capsules 30 Jan 2019 9:57AM $0.265 $0.059 fallen by 77.74%
- Portfolio Update 29 Jan 2019 1:16PM $0.250 $0.059 fallen by 76.40%
- Appendix 3B 24 Jan 2019 2:27PM $0.245 $0.059 fallen by 75.92%
- General meeting proxy form 23 Jan 2019 3:53PM $0.250 $0.059 fallen by 76.40%
- Investor presentation 23 Jan 2019 9:13AM $0.260 $0.059 fallen by 77.31%
- Clarification to Notice of Meeting dated 23 January 2019. 23 Jan 2019 9:12AM $0.260 $0.059 fallen by 77.31%
- General meeting and share purchase plan 23 Jan 2019 9:12AM $0.260 $0.059 fallen by 77.31%
- Fire & Flower achieves CAD$10m sales milestone 22 Jan 2019 11:14AM $0.265 $0.059 fallen by 77.74%
- MediPharm Labs ships over CAD10m of cannabis oil in Dec 2018 17 Jan 2019 9:39AM $0.260 $0.059 fallen by 77.31%
- Net tangible asset backing 14 Jan 2019 8:24AM $0.255 $0.059 fallen by 76.86%
- MediPharm Labs replenishes cannabis inventory to meet demand 11 Jan 2019 9:48AM $0.240 $0.059 fallen by 75.42%
- Harvest One shares trading in United States on OTCQX 10 Jan 2019 9:57AM $0.245 $0.059 fallen by 75.92%
- MediPharm Labs management team increase shareholdings 10 Jan 2019 9:56AM $0.245 $0.059 fallen by 75.92%
- MediPharm Labs extraction agreement with TerrAscend 9 Jan 2019 9:42AM $0.240 $0.059 fallen by 75.42%
- Appendix 3X Michael Curtis 8 Jan 2019 2:46PM $0.240 $0.059 fallen by 75.42%

226 - 250 of 601 results

Page 10 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.